Literature DB >> 21347625

Time-dependent effects of Prkce deletion on glucose homeostasis and hepatic lipid metabolism on dietary lipid oversupply in mice.

K Raddatz1, N Turner, G Frangioudakis, B M Liao, D J Pedersen, J Cantley, D Wilks, E Preston, B D Hegarty, M Leitges, M J Raftery, T J Biden, C Schmitz-Peiffer.   

Abstract

AIMS/HYPOTHESIS: We examined the time-dependent effects of deletion of the gene encoding protein kinase C epsilon (Prkce) on glucose homeostasis, insulin secretion and hepatic lipid metabolism in fat-fed mice.
METHODS: Prkce(-/-) and wild-type (WT) mice were fed a high-fat diet for 1 to 16 weeks and subjected to i.p. glucose tolerance tests (ipGTT) and indirect calorimetry. We also investigated gene expression and protein levels by RT-PCR, quantitative protein profiling (isobaric tag for relative and absolute quantification; iTRAQ) and immunoblotting. Lipid levels, mitochondrial oxidative capacity and lipid metabolism were assessed in liver and primary hepatocytes.
RESULTS: While fat-fed WT mice became glucose intolerant after 1 week, Prkce(-/-) mice exhibited normal glucose and insulin levels. iTRAQ suggested differences in lipid metabolism and oxidative phosphorylation between fat-fed WT and Prkce(-/-) animals. Liver triacylglycerols were increased in fat-fed Prkce(-/-) mice, resulting from altered lipid partitioning which promoted esterification of fatty acids in hepatocytes. In WT mice, fat feeding elevated oxygen consumption in vivo and in isolated liver mitochondria, but these increases were not seen in Prkce(-/-) mice. Prkce(-/-) hepatocytes also exhibited reduced production of reactive oxygen species (ROS) in the presence of palmitate. After 16 weeks of fat feeding, however, the improved glucose tolerance in fat-fed Prkce(-/-) mice was instead associated with increased insulin secretion during ipGTT, as we have previously reported. CONCLUSIONS/
INTERPRETATION: Prkce deletion ameliorates diet-induced glucose intolerance via two temporally distinct phenotypes. Protection against insulin resistance is associated with changes in hepatic lipid partitioning, which may reduce the acute inhibitory effects of fatty acid catabolism, such as ROS generation. In the longer term, enhancement of glucose-stimulated insulin secretion prevails.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21347625     DOI: 10.1007/s00125-011-2073-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  44 in total

Review 1.  Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.

Authors:  Katsutaro Morino; Kitt Falk Petersen; Gerald I Shulman
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

2.  Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance.

Authors:  Timothy R Koves; John R Ussher; Robert C Noland; Dorothy Slentz; Merrie Mosedale; Olga Ilkayeva; James Bain; Robert Stevens; Jason R B Dyck; Christopher B Newgard; Gary D Lopaschuk; Deborah M Muoio
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

Review 3.  Hepatic triacylglycerol accumulation and insulin resistance.

Authors:  Cynthia A Nagle; Eric L Klett; Rosalind A Coleman
Journal:  J Lipid Res       Date:  2008-11-06       Impact factor: 5.922

4.  PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice.

Authors:  K Tordjman; C Bernal-Mizrachi; L Zemany; S Weng; C Feng; F Zhang; T C Leone; T Coleman; D P Kelly; C F Semenkovich
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 5.  Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase.

Authors:  D G Hardie; D A Pan
Journal:  Biochem Soc Trans       Date:  2002-11       Impact factor: 5.407

6.  Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice.

Authors:  Kaori Minehira; Stephen G Young; Claudio J Villanueva; Laxman Yetukuri; Matej Oresic; Mark K Hellerstein; Robert V Farese; Jay D Horton; Frederic Preitner; Bernard Thorens; Luc Tappy
Journal:  J Lipid Res       Date:  2008-06-01       Impact factor: 5.922

7.  IRS1-independent defects define major nodes of insulin resistance.

Authors:  Kyle L Hoehn; Cordula Hohnen-Behrens; Anna Cederberg; Lindsay E Wu; Nigel Turner; Tomoyuki Yuasa; Yousuke Ebina; David E James
Journal:  Cell Metab       Date:  2008-05       Impact factor: 27.287

8.  Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance.

Authors:  Takashi Matsuzaka; Hitoshi Shimano; Naoya Yahagi; Toyonori Kato; Ayaka Atsumi; Takashi Yamamoto; Noriyuki Inoue; Mayumi Ishikawa; Sumiyo Okada; Naomi Ishigaki; Hitoshi Iwasaki; Yuko Iwasaki; Tadayoshi Karasawa; Shin Kumadaki; Toshiyuki Matsui; Motohiro Sekiya; Ken Ohashi; Alyssa H Hasty; Yoshimi Nakagawa; Akimitsu Takahashi; Hiroaki Suzuki; Sigeru Yatoh; Hirohito Sone; Hideo Toyoshima; Jun-ichi Osuga; Nobuhiro Yamada
Journal:  Nat Med       Date:  2007-09-30       Impact factor: 53.440

Review 9.  Metabolic stress in insulin's target cells leads to ROS accumulation - a hypothetical common pathway causing insulin resistance.

Authors:  Jan W Eriksson
Journal:  FEBS Lett       Date:  2007-06-27       Impact factor: 4.124

Review 10.  Protein kinase C function in muscle, liver, and beta-cells and its therapeutic implications for type 2 diabetes.

Authors:  Carsten Schmitz-Peiffer; Trevor J Biden
Journal:  Diabetes       Date:  2008-07       Impact factor: 9.461

View more
  23 in total

1.  Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes.

Authors:  Leigh Goedeke; Rachel J Perry; Gerald I Shulman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-01-06       Impact factor: 13.820

2.  Deletion of protein kinase Cε in mice has limited effects on liver metabolite levels but alters fasting ketogenesis and gluconeogenesis.

Authors:  K Raddatz; G Frangioudakis; B Diakanastasis; B M Liao; M Leitges; C Schmitz-Peiffer
Journal:  Diabetologia       Date:  2012-07-20       Impact factor: 10.122

Review 3.  Mechanisms for insulin resistance: common threads and missing links.

Authors:  Varman T Samuel; Gerald I Shulman
Journal:  Cell       Date:  2012-03-02       Impact factor: 41.582

Review 4.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

5.  XBP1s Is an Anti-lipogenic Protein.

Authors:  Hilde Herrema; Yingjiang Zhou; Dongyan Zhang; Justin Lee; Mario Andres Salazar Hernandez; Gerald I Shulman; Umut Ozcan
Journal:  J Biol Chem       Date:  2016-06-20       Impact factor: 5.157

6.  Protein Kinase C Epsilon Is a Key Regulator of Mitochondrial Redox Homeostasis in Acute Myeloid Leukemia.

Authors:  Daniela Di Marcantonio; Esteban Martinez; Simone Sidoli; Jessica Vadaketh; Margaret Nieborowska-Skorska; Anushk Gupta; Jake M Meadows; Francesca Ferraro; Elena Masselli; Grant A Challen; Michael D Milsom; Claudia Scholl; Stefan Fröhling; Siddharth Balachandran; Tomasz Skorski; Benjamin A Garcia; Prisco Mirandola; Giuliana Gobbi; Ramiro Garzon; Marco Vitale; Stephen M Sykes
Journal:  Clin Cancer Res       Date:  2017-11-10       Impact factor: 12.531

7.  A Membrane-Bound Diacylglycerol Species Induces PKCϵ-Mediated Hepatic Insulin Resistance.

Authors:  Kun Lyu; Ye Zhang; Dongyan Zhang; Mario Kahn; Kasper W Ter Horst; Marcos R S Rodrigues; Rafael C Gaspar; Sandro M Hirabara; Panu K Luukkonen; Seohyuk Lee; Sanjay Bhanot; Jesse Rinehart; Niels Blume; Morten Grønbech Rasch; Mireille J Serlie; Jonathan S Bogan; Gary W Cline; Varman T Samuel; Gerald I Shulman
Journal:  Cell Metab       Date:  2020-09-02       Impact factor: 27.287

Review 8.  The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux.

Authors:  Varman T Samuel; Gerald I Shulman
Journal:  J Clin Invest       Date:  2016-01-04       Impact factor: 14.808

9.  Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance.

Authors:  Max C Petersen; Anila K Madiraju; Brandon M Gassaway; Michael Marcel; Ali R Nasiri; Gina Butrico; Melissa J Marcucci; Dongyan Zhang; Abudukadier Abulizi; Xian-Man Zhang; William Philbrick; Stevan R Hubbard; Michael J Jurczak; Varman T Samuel; Jesse Rinehart; Gerald I Shulman
Journal:  J Clin Invest       Date:  2016-10-17       Impact factor: 14.808

Review 10.  Regulation of Glucose Production in the Pathogenesis of Type 2 Diabetes.

Authors:  Ashot Sargsyan; Mark A Herman
Journal:  Curr Diab Rep       Date:  2019-08-03       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.